Fakhreddin Jamali

Last updated
Fakhreddin Jamali
Fakhreddin Jamali.jpg
Born (1945-05-31) May 31, 1945 (age 78)
Education University of British Columbia (PhD)
University of Tehran (Pharm.D.)
Known forfounding the Canadian Society for Pharmaceutical Sciences
Spouse(s)Elaheh Keshavarz-Jamali, PharmD, PhD (b. 1945- d. 2020) [1]
ChildrenVafa Jamali [1]
Awards Alberta Centennial Medal, AAPS fellowship, CSPS fellowship, Killam Professorship
Scientific career
Fields pharmaceutical sciences
Institutions University of Alberta

Fakhreddin Jamali (born May 31, 1945) is an Iranian-Canadian professor emeritus of pharmacy and pharmaceutical sciences at the University of Alberta. He is the founding president of the Canadian Society for Pharmaceutical Sciences, [2] and the editor-in-chief of Journal of Pharmacy and Pharmaceutical Sciences . [3]

Contents

Early life

Fakhreddin was born May 31, 1945, in Arak, Iran to Jamaleddin Jamali and Batoul Rouhani-Jamali. [4] [5]

Career

Jamali's focus has been on drugs action (pharmacodynamics) and disposition (pharmacokinetics) particularly in field of analgesics and antiinfammatory therapy. His earlier work on the stereoselective and stereospecific therapeutic and toxicity of drugs received high peer recognition. [6] He also reported that pain and/or its trauma delays absorption of drugs which may render them ineffective. [7] This is particularly important when a quick action is desired such as pain relief. His group found that inflammatory conditions such as arthritis diminish response to some cardiovascular drugs despite already known increased circulatory concentrations. [8] His group also has reported the mechanism behind the adverse cardiovascular effects of both anti-inflammatory drugs and inflammatory conditions. [9] [10] Jamali has received many national and international awards for his contribution to science and public wellbeing. [11]

Related Research Articles

<span class="mw-page-title-main">Ketoprofen</span> Chemical compound

Ketoprofen is one of the propionic acid class of nonsteroidal anti-inflammatory drugs (NSAID) with analgesic and antipyretic effects. It acts by inhibiting the body's production of prostaglandin.

<span class="mw-page-title-main">Nonsteroidal anti-inflammatory drug</span> Class of therapeutic drug for relieving pain and inflammation

Non-steroidal anti-inflammatory drugs (NSAID) are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever, and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.

<span class="mw-page-title-main">Ibuprofen</span> Medication used for treating pain, fever, and inflammation

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that is used to relieve pain, fever, and inflammation. This includes painful menstrual periods, migraines, and rheumatoid arthritis. It may also be used to close a patent ductus arteriosus in a premature baby. It can be used orally or intravenously. It typically begins working within an hour.

<span class="mw-page-title-main">Diclofenac</span> Nonsteroidal anti-inflammatory drug

Diclofenac, sold under the brand name Voltaren, among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammatory diseases such as gout. It is taken by mouth or rectally in a suppository, used by injection, or applied to the skin. Improvements in pain last for as much as eight hours. It is also available in combination with misoprostol in an effort to decrease stomach problems.

<span class="mw-page-title-main">Naproxen</span> Nonsteroidal anti-inflammatory drug (NSAID) used to treat pain

Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, gout and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and lasts for up to twelve hours.

<span class="mw-page-title-main">Celecoxib</span> Nonsteroidal anti-inflammatory drug

Celecoxib, sold under the brand name Celebrex among others, is a COX-2 inhibitor and nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheumatoid arthritis. It may also be used to decrease the risk of colorectal adenomas in people with familial adenomatous polyposis. It is taken by mouth. Benefits are typically seen within an hour.

Anti-inflammatory or antiphlogistic is the property of a substance or treatment that reduces inflammation or swelling. Anti-inflammatory drugs, also called anti-inflammatories, make up about half of analgesics. These drugs remedy pain by reducing inflammation as opposed to opioids, which affect the central nervous system to block pain signaling to the brain.

COX-2 inhibitors (coxibs) are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly target cyclooxygenase-2, COX-2, an enzyme responsible for inflammation and pain. Targeting selectivity for COX-2 reduces the risk of peptic ulceration and is the main feature of celecoxib, rofecoxib, and other members of this drug class.

<span class="mw-page-title-main">Etodolac</span> Nonsteroidal Anti-Inflammatory Drug

Etodolac is a nonsteroidal anti-inflammatory drug (NSAID).

<span class="mw-page-title-main">Diflunisal</span> Nonsteroidal anti-inflammatory (NSAID), Used as an analgesic & anti inflammatory

Diflunisal is a salicylic acid derivative with analgesic and anti-inflammatory activity. It was developed by Merck Sharp & Dohme in 1971, as MK647, after showing promise in a research project studying more potent chemical analogs of aspirin. It was first sold under the brand name Dolobid, marketed by Merck & Co., but generic versions are now widely available. It is classed as a nonsteroidal anti-inflammatory drug (NSAID) and is available in 250 mg and 500 mg tablets.

<span class="mw-page-title-main">Nabumetone</span> Chemical compound

Nabumetone is a nonsteroidal anti-inflammatory drug (NSAID). Nabumetone was developed by Beecham and first received regulatory approval in 1991. It is available under numerous brand names, such as Relafen, Relifex, and Gambaran.

A prostaglandin antagonist is a hormone antagonist acting upon one or more prostaglandins, a subclass of eicosanoid compounds which function as signaling molecules in numerous types of animal tissues.

<span class="mw-page-title-main">Flunoxaprofen</span> Chemical compound

Flunoxaprofen, also known as Priaxim, is a chiral nonsteroidal anti-inflammatory drug (NSAID). It is closely related to naproxen, which is also an NSAID. Flunoxaprofen has been shown to significantly improve the symptoms of osteoarthritis and rheumatoid arthritis. The clinical use of flunoxaprofen has ceased due to concerns of potential hepatotoxicity.

<span class="mw-page-title-main">Dexibuprofen</span> Chemical compound

Dexibuprofen is a nonsteroidal anti-inflammatory drug (NSAID).

<span class="mw-page-title-main">Fenoprofen</span> Chemical compound

Fenoprofen, sold under the brand name Nalfon among others, is a nonsteroidal anti-inflammatory drug (NSAID). Fenoprofen calcium is used for symptomatic relief for rheumatoid arthritis, osteoarthritis, and mild to moderate pain. It has also been used to treat postoperative pain. It is available as a generic medication.

<span class="mw-page-title-main">Tenoxicam</span> Chemical compound

Tenoxicam, sold under the brand name Mobiflex among others, is a nonsteroidal anti-inflammatory drug (NSAID). It is used to relieve inflammation, swelling, stiffness, and pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, and periarthritis of the shoulders or hips.

COX-inhibiting nitric oxide donators (CINODs), also known as NO-NSAIDs, are a new class of nonsteroidal anti-inflammatory drug (NSAID) developed with the intention of providing greater safety than existing NSAIDs.

Prostaglandin inhibitors are drugs that inhibit the synthesis of prostaglandin in human body. There are various types of prostaglandins responsible for different physiological reactions such as maintaining the blood flow in stomach and kidney, regulating the contraction of involuntary muscles and blood vessels, and act as a mediator of inflammation and pain. Cyclooxygenase (COX) and Phospholipase A2 are the major enzymes involved in prostaglandin production, and they are the drug targets for prostaglandin inhibitors. There are mainly 2 classes of prostaglandin inhibitors, namely non- steroidal anti- inflammatory drugs (NSAIDs) and glucocorticoids. In the following sections, the medical uses, side effects, contraindications, toxicity and the pharmacology of these prostaglandin inhibitors will be discussed.

<span class="mw-page-title-main">Antiarthritics</span>

An antiarthritic is any member of the group of drugs used to relieve or prevent arthritic symptoms, such as joint pain and joint stiffness. Depending on the antiarthritic drug class, it can be responsible for managing pain, reducing inflammation and/or acting as an immunosuppressant. These drugs are typically given orally, topically or through administration by injection. The choice of antiarthritic medication is often determined by the type/nature of arthritis, the severity of symptoms as well as other factors, such as the tolerability of side effects.

Ibuprofen/famotidine, sold under the brand name Duexis, is a fixed-dose combination medication used for the treatment of rheumatoid arthritis and osteoarthritis. It contains ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) and famotidine, a histamine H2-receptor antagonist.

References

  1. 1 2 "Dr. Fakhreddin Jamali: Pharmacist, Pharmaceutical Scientist and Mentor".
  2. "2018 Board of Directors". Cspscanada.org. Retrieved 17 January 2019.
  3. "Editorial Team". Journals.library.ualberta.ca. Retrieved 12 August 2018.
  4. "سخنرانی دکتر فخرالدین جمالی در دانشکده داروسازی". Tehran University of Medical Sciences . Retrieved 26 January 2019.
  5. "کانون سردفتران و دفتریاران". www.notary.ir. Retrieved 26 January 2019.
  6. Jamali, F.; Mehvar, R.; Pasutto, F. M. (1 September 1989). "Enantioselective Aspects of Drug Action and Disposition: Therapeutic Pitfalls". Journal of Pharmaceutical Sciences. 78 (9): 695–715. doi:10.1002/jps.2600780902. ISSN   0022-3549. PMID   2685226.
  7. Jamali, Fakhreddin; Kunz-Dober, Cornelia M. (April 1999). "Pain-mediated altered absorption and metabolism of ibuprofen: an explanation for decreased serum enantiomer concentration after dental surgery: Pain-mediated altered absorption of ibuprofen". British Journal of Clinical Pharmacology. 47 (4): 391–396. doi:10.1046/j.1365-2125.1999.00902.x. PMC   2014238 . PMID   10233203.
  8. Abdallah, Yasmeen El Hajj; Chahal, Sukhman; Jamali, Fakhreddin; Mahmoud, Sherif Hanafy (2023). "Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition". Journal of Pharmacy & Pharmaceutical Sciences. 26: 11137. doi: 10.3389/jpps.2023.11137 . ISSN   1482-1826. PMC   9990632 . PMID   36942294.
  9. Aghazadeh-Habashi, Ali; Asghar, Waheed; Jamali, Fakhreddin (1 February 2018). "Drug-Disease Interaction: Effect of Inflammation and Nonsteroidal Anti-Inflammatory Drugs on Cytochrome P450 Metabolites of Arachidonic Acid". Journal of Pharmaceutical Sciences. 107 (2): 756–763. doi:10.1016/j.xphs.2017.09.020. ISSN   0022-3549. PMID   28989019.
  10. Asghar, Waheed; Aghazadeh-Habashi, Ali; Jamali, Fakhreddin (1 October 2017). "Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin–angiotensin system in experimental arthritis". Inflammopharmacology. 25 (5): 543–553. doi:10.1007/s10787-017-0344-1. ISSN   1568-5608. PMID   28389995. S2CID   254576802.
  11. "Fakhreddin Jamali". International Pharmaceutical Federation.